newsfilter
← Latest News
GlobeNewswire·

180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren's Disease Treatment and Application

PALO ALTO, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that the United States Patent and Trademark Office (USPTO) has issued